Bioventus Inc.BVSNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 6.37% |
| Q3 2025 | -1.65% |
| Q2 2025 | 7.63% |
| Q1 2025 | -15.14% |
| Q4 2024 | 6.81% |
| Q3 2024 | -16.11% |
| Q2 2024 | 22.71% |
| Q1 2024 | 0.53% |
| Q4 2023 | 12.23% |
| Q3 2023 | -6.71% |
| Q3 2023 | -7.44% |
| Q2 2023 | 4.11% |
| Q4 2022 | -1.63% |
| Q4 2022 | -11.90% |
| Q3 2022 | 4.06% |
| Q2 2022 | 6.48% |
| Q4 2021 | 16.15% |
| Q4 2021 | 0.85% |
| Q3 2021 | 99.07% |
| Q2 2021 | -44.03% |
| Q4 2020 | 23.22% |
| Q3 2020 | 24.08% |
| Q2 2020 | 0.64% |
| Q1 2020 | -26.04% |
| Q4 2019 | 20.69% |
| Q3 2019 | -8.76% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q1 2016 | 0.00% |
| Q1 2015 | 0.00% |